A population-based study of dna repair gene variants in relation to non-melanoma skin cancer as a marker of a cancer-prone phenotype

Carcinogenesis

Volumn 33, Issue 9, 2012, Pages 1692-1698

  Ruczinski, Ingo ^a   Jorgensen, Timothy J ^b   Shugart, Yin Yao ^c   Schaad, Yvette Berthier ^a,d   Kessing, Bailey ^d   Hoffman Bolton, Judith ^a,e   Helzlsouer, Kathy J ^f   Kao, W H Linda ^a   Wheless, Lee ^g   Francis, Lesley ^g   Alani, Rhoda M ^h   Strickland, Paul T ^a,i   Smith, Michael W ^d   Alberg, Anthony J ^g  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^d SAIC FREDERICK INC   (United States)

^e George W Comstock Center for Public Health Research and Prevention   (United States)

^f MERCY MEDICAL CENTER   (United States)

^g MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^h BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ The Johns Hopkins University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DNA REPAIR; FEMALE; GENE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NON MELANOMA SKIN CANCER; PHENOTYPE; POPULATION RESEARCH; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; THYMINE DNA GLYCOSYLASE GENE;

ADULT; AGED; DNA HELICASES; DNA REPAIR; DNA-BINDING PROTEINS; FEMALE; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; SKIN NEOPLASMS; THYMINE DNA GLYCOSYLASE; TUMOR MARKERS, BIOLOGICAL;

EID: 84865538112     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgs170     Document Type: Article

References (44)

1. Rogers, H.W. et al. (2010) Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch. Dermatol., 146, 283-287.
2. Wheless, L. et al. (2010) Nonmelanoma skin cancer and the risk of second primary cancers: a systematic review. Cancer Epidemiol. Biomarker Prev., 19, 1686-1695.
3. Cleaver, J.E. (2000) Common pathways for ultraviolet skin carcinogenesis in the repair and replication defective groups of xeroderma pigmentosum. J. Dermatol. Sci., 23, 1-11.
4. Cleaver, J.E. (2005) Cancer in xeroderma pigmentosum and related disorders of DNA repair. Nat. Rev. Cancer, 5, 564-573.
5. German, J. (1997) Bloom's syndrome. XX. The first 100 cancers. Cancer Genet. Cytogenet., 93, 100-106.
6. Thomas, E.R.A. et al. (2008) Surveillance and treatment of malignancy in Bloom's Syndrome. Clin. Oncol., 20, 375-379.
7. Vineis, P. et al. (2009) A field synopsis on low-penetrance variants in DNA repair genes and cancer susceptibility. J. Natl. Cancer Inst., 101, 24-36.
8. Halliday, G.M. (2005) Inflammation, gene mutation and photoimmunosuppression in response to UVR-induced oxidative damage contributes to photocarcinogenesis. Mutat. Res., 571, 107-120.
9. Cadet, J. et al. (2005) Ultraviolet radiation-mediated damage to cellular DNA. Mutat. Res., 571, 3-17.
10. Chen, J. et al. (2008) Nonmelanoma skin cancer and risk for subsequent malignancy. J. Natl. Cancer Inst., 100, 1215-1222.
11. Gallicchio, L. et al. (2009) Single nucleotide polymorphisms in obesityrelated genes and all-cause and cause-specific mortality: a prospective cohort study. BMC Med. Genet., 10, 103.
12. Jorgensen, T.J. et al. (2009) Hypothesis-driven candidate gene association studies: practical design and analytical considerations. Am. J. Epidemiol., 170, 986-993.
13. Wood, R.D. et al. (2005) Human DNA repair genes, 2005. Mutat. Res., 577, 275-283.
14. de Bakker, P.I. et al. (2005) Efficiency and power in genetic association studies. Nat. Genet., 37, 1217-1223.
15. Wigginton, J.E. et al. (2005) A note on exact tests of Hardy-Weinberg equilibrium. Am. J. Hum. Genet., 76, 887-893.
16. Broderick, P. et al. (2006) Evaluation of NTHL1, NEIL1, MPG, TDG, UNG, and SMUG1 genes in familial colorectal cancer predisposition. BMC Cancer, 6, 243.
17. Cortazar, D. et al. (2007) The enigmatic thymine DNA glycosylase. DNA Repair, 6, 489-504.
18. Cortázar, D. et al. (2011) Embryonic lethal phenotype reveals a function of TDG in maintaining epigenetic stability. Nature, 470, 419-423.
19. Cortellino, S. et al. (2011) Thymine DNA glycosylase is essential for active DNA demethylation by linked deamination-base excision repair. Cell, 146, 67-79.
20. He, Y.F. et al. (2011) Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science, 333, 1303-1307.
21. Kim, E.-J. et al. (2008) Thymine-DNA glycosylase interacts with and functions as a coactivator of p53 family proteins. Biochem. Biophys. Res. Commun., 377, 838-842.
22. Chanson, A. et al. (2009) Polymorphisms in uracil-processing genes, but not one-carbon nutrients, are associated with altered DNA uracil concentrations in an urban Puerto Rican population. Am. J. Clin. Nutr., 89, 1927-1936.
23. Krzesniak, M. et al. (2004) Polymorphisms in TDG and MGMT genes- epidemiological and functional study in lung cancer patients from Poland. Ann. Hum. Genet., 68, 300-312.
24. Curtin, K. et al. (2011) Candidate pathway polymorphisms in one-carbon metabolism and risk of rectal tumor mutations. Int. J. Mol. Epidemiol. Genet., 2, 1-8.
25. Wen-Bin, M. et al. (2009) Micronucleus occurrence related to base excision repair gene polymorphisms in Chinese workers occupationally exposed to vinyl chloride monomer. J. Occup. Environ. Med., 51, 578-585.
26. Bethke, L. et al. (2008) Comprehensive analysis of the role of DNA repair gene polymorphisms on risk of glioma. Hum. Mol. Genet., 17, 800-805.
27. Thyagarajan, B. et al. (2010) Association between genetic variants in the base excision repair pathway and outcomes after hematopoietic cell transplantations. Biol. Blood Marrow Transplant., 16, 1084-1089.
28. Tischkowitz, M. et al. (2010) PALB2/FANCN: recombining cancer and Fanconi anemia. Cancer Res., 70, 7353-7359.
29. Bogdanova, N. et al. (2011) PALB2 mutations in German and Russian patients with bilateral breast cancer. Breast Cancer Res. Treat., 126, 545-550.
30. Papi, L. et al. (2010) A PALB2 germline mutation associated with hereditary breast cancer in Italy. Fam. Cancer, 9, 181-185.
31. Garcia, M.J. et al. (2009) Analysis of FANCB and FANCN/PALB2 Fanconi anemia genes in BRCA1/2-negative Spanish breast cancer families. Breast Cancer Res. Treat., 113, 545-551.
32. Erkko, H. et al. (2007) A recurrent mutation in PALB2 in Finnish cancer families. Nature, 446, 316-319.
33. Cao, A-Y. et al. (2010) Five common single nucleotide polymorphisms in the PALB2 gene and susceptibility to breast cancer in eastern Chinese population. Breast Cancer Res. Treat., 123, 133-138.
34. Narod, S.A. (2010) Testing for CHEK2 in the cancer genetics clinic: ready for prime time? Clin. Genet., 78, 1-7.
35. Nevanlinna, H. et al. (2006) The CHEK2 gene and inherited breast cancer susceptibility. Oncogene, 25, 5912-5919.
36. Baynes, C. et al. (2007) Common variants in the ATM1, BRCA1, BRCA2, CHEK2, and TP53 cancer susceptibility genes are unlikely to increase breast cancer risk. Breast Cancer Res., 9, R27.
37. Laugel, V. et al. (2010) Mutation update for the CSB/ERCC6 gene and CSA/ ERCC8 genes involved in Cockayne syndrome. Hum. Mutat., 31, 113-126.
38. Oh, K.-S. et al. (2006) Phenotypic heterogeneity in the XPB DNA helicase gene (ERCC3): Xeroderma pigmentosum without and with Cockayne syndrome. Hum. Mutat., 27, 1092-1103.
39. Rybanska, I. et al. (2010) Newly identified CHO ERCC3/XPB muations and phenotype characterization. Mutagenesis, 25, 179-185.
40. Kagawa, W. et al. (2010) From meiosis to postmeiotic events: uncovering the molecular roles of the meiosis-specific recombinase Dmc1. FEBS J, 277, 590-598.
41. Wang, S.S. et al. (2010) Common genetic variants and risk for HPV persistence and progression to cervical cancer. PLoS One, 5, e8667.
42. Pineda, M. et al. (2010) Detection of genetic alterations in heredity colorectal cancer screening. Mutat. Res., 693, 19-31.
43. Bansal, N. et al. (2009) The molecular biology of endometrial cancers and the implications for pathogenesis, classification, and targeted therapies. Cancer Control, 16, 8-13.
44. Tubbs, J.L. et al. (2007) DNA binding, nucleotide flipping, and the helixturn-helix motif in base repair by O6-alkylguanine-DNA-alkyltransferase and its implications for cancer chemotherapy. DNA Repair, 6, 1100-1115.